Variants grouped by gene
The researchers used data from three studies: PASIDA, PEG and PPMI. They examined sets of common or less common genetic variants, grouped within regions of genes already implicated in Parkinson’s or depression.
The outcomes measured included a history of a depression diagnosis and current depressive symptoms. This was not a test of an intervention. The available abstract specifies neither the total sample size nor the follow-up duration, limiting assessment of the findings’ scope.
A signal for KRTCAP2
Among genes linked to Parkinson’s, KRTCAP2 showed an association with a self-reported depression diagnosis. This association persisted after false discovery rate correction, a method intended to limit positive findings arising from multiple testing.
A higher genetic burden in KRTCAP2 was associated with an odds ratio of 1.20, with a 95% confidence interval of 1.04 to 1.38. This result does not mean a 20-percentage-point increase in the probability of depression. The abstract does not provide an absolute difference that would allow this association to be translated into a concrete risk.
TRAF5 and LRRK2 showed associations described by the authors as marginal. Among genes previously linked to depression, SPPL3 and ERBB4 were associated with a history of diagnosis, and FNIP2 with current symptoms.
Partly shared genetic susceptibility
The polygenic risk score for depression, which combines information from multiple variants, was also associated with a depression diagnosis in these patients. In contrast, the polygenic score for Parkinson’s did not show this association.
This contrast suggests that a general genetic susceptibility to depression could contribute to depressive symptoms in Parkinson’s. The authors also discuss immune-related genes as possible contributors. This remains a biological hypothesis, not evidence of a causal mechanism or an effective therapeutic target.
Limitations to keep in mind
Only the PubMed abstract was consulted. The sample size, follow-up duration, detailed statistical adjustments, funding and conflicts of interest could not be verified. The findings concern patients of European ancestry and cannot be directly generalized to other populations. A genetic association does not demonstrate causality.
What we can take away
This study offers leads on the genetics of depression in Parkinson’s. It does not validate any genetic screening or change in treatment.
Sources and provenance
- Gene-based association analysis of depression risk among European ancestry Parkinson's disease patients.
Source date: 2026-10-17.
Journal Article, Meta-Analysis · Résumé PubMed uniquement, texte intégral non consulté